ebola incubation period
YOUR COMMENTS: A multi-million dollar deal has been signed to provide 300,000 doses of an experimental ebola incubation period vaccine.
The agreement – between drugs company Merck and GAVI, the Global Vaccine Alliance – was announced today at the World Economic Forum in Davos.
Will it make any difference in fighting the virus? Or is it a risk, as the vaccine has not yet been fully licenced?